How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive CardiologyShow others and affiliations
2023 (English)In: European Journal of Preventive Cardiology, ISSN 2047-4873, E-ISSN 2047-4881, Vol. 30, no 2, p. 149-166Article in journal (Refereed) Published
Abstract [en]
A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for CVD risk factors and CVD have been observed consistently over the last few decades. Hence, achieving optimal adherence to lifestyle measures and guideline-directed medical therapy in secondary prevention and rehabilitation is a great challenge to many healthcare professionals. Therefore, in this European Association of Preventive Cardiology clinical consensus document, a modern reappraisal of the adherence to optimal treatment is provided, together with simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.
Place, publisher, year, edition, pages
OXFORD UNIV PRESS , 2023. Vol. 30, no 2, p. 149-166
Keywords [en]
Cardiovascular disease; Cardiovascular risk; Secondary prevention; Adherence
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:liu:diva-189091DOI: 10.1093/eurjpc/zwac204ISI: 000861564600001PubMedID: 36098041Scopus ID: 2-s2.0-85147048434OAI: oai:DiVA.org:liu-189091DiVA, id: diva2:1702706
2022-10-112022-10-112025-02-10